-+ 0.00%
-+ 0.00%
-+ 0.00%

Pliant Therapeutics Reports Q2 2025 Results: Net Loss Decreases to $43.3M Amid Workforce Restructuring; R&D Expenses Down Due to BEACON-IPF Discontinuation

Reuters·08/07/2025 20:06:31

Please log in to view news